CA2108144A1
(en)
*
|
1991-03-06 |
1992-09-07 |
Jack A. Roth |
Methods and compositions for the selective inhibition of gene expression
|
US5747469A
(en)
*
|
1991-03-06 |
1998-05-05 |
Board Of Regents, The University Of Texas System |
Methods and compositions comprising DNA damaging agents and p53
|
US6410010B1
(en)
|
1992-10-13 |
2002-06-25 |
Board Of Regents, The University Of Texas System |
Recombinant P53 adenovirus compositions
|
DE4311651A1
(de)
*
|
1993-04-08 |
1994-10-13 |
Boehringer Ingelheim Int |
Virus für den Transport von Fremd-DNA in höhere eukaryotische Zellen
|
FR2704234B1
(fr)
*
|
1993-04-22 |
1995-07-21 |
Centre Nat Rech Scient |
Virus recombinants, preparation et utilisation en therapie genique.
|
US5543328A
(en)
*
|
1993-08-13 |
1996-08-06 |
Genetic Therapy, Inc. |
Adenoviruses having modified fiber proteins
|
US6312699B1
(en)
*
|
1994-03-28 |
2001-11-06 |
Uab Research Foundation |
Ligands added to adenovirus fiber
|
US7252989B1
(en)
|
1994-04-04 |
2007-08-07 |
Board Of Regents, The University Of Texas System |
Adenovirus supervector system
|
GB9410922D0
(en)
*
|
1994-06-01 |
1994-07-20 |
Townsend Alain R M |
Vaccines
|
US6465253B1
(en)
|
1994-09-08 |
2002-10-15 |
Genvec, Inc. |
Vectors and methods for gene transfer to cells
|
US5965541A
(en)
*
|
1995-11-28 |
1999-10-12 |
Genvec, Inc. |
Vectors and methods for gene transfer to cells
|
US5846782A
(en)
|
1995-11-28 |
1998-12-08 |
Genvec, Inc. |
Targeting adenovirus with use of constrained peptide motifs
|
US5559099A
(en)
*
|
1994-09-08 |
1996-09-24 |
Genvec, Inc. |
Penton base protein and methods of using same
|
US5962311A
(en)
*
|
1994-09-08 |
1999-10-05 |
Genvec, Inc. |
Short-shafted adenoviral fiber and its use
|
FR2724320B1
(fr)
|
1994-09-13 |
1996-12-20 |
Transgene Sa |
Nouvel implant pour le traitement des maladies acquises
|
AU780164B2
(en)
*
|
1994-09-13 |
2005-03-03 |
Transgene S.A. |
Novel implant and novel vector for the treatment of acquired diseases
|
US5518042A
(en)
*
|
1994-09-16 |
1996-05-21 |
Huyck Licensco, Inc. |
Papermaker's forming fabric with additional cross machine direction locator and fiber supporting yarns
|
US5770442A
(en)
*
|
1995-02-21 |
1998-06-23 |
Cornell Research Foundation, Inc. |
Chimeric adenoviral fiber protein and methods of using same
|
US6127525A
(en)
*
|
1995-02-21 |
2000-10-03 |
Cornell Research Foundation, Inc. |
Chimeric adenoviral coat protein and methods of using same
|
US6379669B1
(en)
*
|
1995-08-04 |
2002-04-30 |
Akhouri A. Sinha |
Targeting of organs by immunoconjugates
|
KR100353115B1
(ko)
|
1995-11-13 |
2003-01-06 |
다카라츠죠 가부시키가이샤 |
레트로바이러스를사용한표적세포내로의유전자도입방법
|
BR9612685A
(pt)
*
|
1995-11-28 |
1999-07-20 |
Genvec Inc |
Vetores e métodos para transferéncia de gene para células
|
JP2001520511A
(ja)
*
|
1995-12-08 |
2001-10-30 |
ザ ユーナヴァーサティ オブ アラバマ アト バーミングハム リサーチ ファンデーション |
向標的性アデノウイルス・ベクター
|
US20020193580A1
(en)
*
|
1995-12-15 |
2002-12-19 |
Mitchell Lloyd G. |
Methods and compositions for use in spliceosome mediated RNA trans-splicing
|
US20060088938A1
(en)
*
|
1995-12-15 |
2006-04-27 |
Mitchell Lloyd G |
Methods and compositions for use in spliceosome mediated RNA trans-splicing in plants
|
US20030027250A1
(en)
*
|
1995-12-15 |
2003-02-06 |
Mitchell Lloyd G. |
Methods and compositions for use in spliceosome mediated RNA trans-splicing
|
WO1997023608A1
(en)
*
|
1995-12-22 |
1997-07-03 |
Chiron Corporation |
Compositions and methods for targeting gene delivery vehicles using covalently bound targeting elements
|
EP0927044A4
(en)
*
|
1996-04-16 |
1999-09-08 |
Immusol Inc |
DEFINED TARGET VIRAL VECTORS
|
US5958892A
(en)
|
1996-07-30 |
1999-09-28 |
Board Of Regents, The University Of Texas System |
2-methoxyestradiol-induced apoptosis in cancer cells
|
AU742018B2
(en)
*
|
1996-08-21 |
2001-12-13 |
Genvec, Inc. |
Alternatively targeted adenovirus
|
WO1998040508A1
(en)
*
|
1997-03-14 |
1998-09-17 |
Selective Genetics, Inc. |
Adenoviral vectors with modified tropism
|
ATE388720T1
(de)
|
1997-04-10 |
2008-03-15 |
Univ Southern California |
Sich an extrazelluläre matrixbestandteile anbindende modifizierte proteine
|
WO1998049195A1
(en)
*
|
1997-04-29 |
1998-11-05 |
Universiteit Utrecht |
Corona virus-like particles as tools for vaccination and therapy
|
GB9709421D0
(en)
|
1997-05-10 |
1997-07-02 |
Zeneca Ltd |
Chemical compounds
|
US6004798A
(en)
*
|
1997-05-14 |
1999-12-21 |
University Of Southern California |
Retroviral envelopes having modified hypervariable polyproline regions
|
CA2291323A1
(en)
*
|
1997-05-28 |
1998-12-03 |
Genvec, Inc. |
Alternatively targeted adenovirus
|
AU8605598A
(en)
*
|
1997-07-31 |
1999-02-22 |
University Of Pittsburgh |
Targeted hsv vectors
|
US6706693B1
(en)
|
1997-08-13 |
2004-03-16 |
The Uab Research Foundation |
Vaccination by topical application of genetic vectors
|
US20030045492A1
(en)
*
|
1997-08-13 |
2003-03-06 |
Tang De-Chu C. |
Vaccination by topical application of recombinant vectors
|
US6716823B1
(en)
|
1997-08-13 |
2004-04-06 |
The Uab Research Foundation |
Noninvasive genetic immunization, expression products therefrom, and uses thereof
|
US6348450B1
(en)
|
1997-08-13 |
2002-02-19 |
The Uab Research Foundation |
Noninvasive genetic immunization, expression products therefrom and uses thereof
|
US20030125278A1
(en)
*
|
1997-08-13 |
2003-07-03 |
Tang De-Chu C. |
Immunization of animals by topical applications of a salmonella-based vector
|
EP1032420A4
(en)
*
|
1997-11-14 |
2004-09-15 |
Euro Celtique Sa |
IMMUNOGLOBULIN MOLECULES WITH SYNTHETIC VARIABLE REGION AND MODIFIED SPECIFICITY
|
IL137681A0
(en)
*
|
1998-02-06 |
2001-10-31 |
Uab Research Foundation |
Adenovirus vector containing a heterologous peptide epitope in the hi loop of the fiber knob
|
US6815200B1
(en)
|
1998-02-17 |
2004-11-09 |
The Uab Research Foundation |
Modified adenovirus containing a fiber replacement protein
|
US20050095231A1
(en)
*
|
1998-02-17 |
2005-05-05 |
Curiel David T. |
Modified adenovirus containing a fiber replacement protein
|
US6210946B1
(en)
*
|
1998-02-17 |
2001-04-03 |
Uab Research Foundation |
Modified adenovirus containing a fiber replacement protein
|
WO1999047180A1
(en)
*
|
1998-03-20 |
1999-09-23 |
Genzyme Corporation |
Chimeric adenoviral vectors for targeted gene delivery
|
US7078483B2
(en)
|
1998-04-29 |
2006-07-18 |
University Of Southern California |
Retroviral vectors including modified envelope escort proteins
|
AU4070499A
(en)
|
1998-04-30 |
1999-11-16 |
Cornell Research Foundation Inc. |
Adenoviral vectors with tandem fiber proteins
|
US20030017138A1
(en)
|
1998-07-08 |
2003-01-23 |
Menzo Havenga |
Chimeric adenoviruses
|
AU767975B2
(en)
|
1998-09-11 |
2003-11-27 |
Genvec, Inc. |
Alternatively targeted adenovirus
|
US6524571B1
(en)
*
|
1998-10-16 |
2003-02-25 |
Anticancer, Inc. |
Methioninase gene therapy for tumor treatment
|
US6303362B1
(en)
|
1998-11-19 |
2001-10-16 |
The Board Of Trustees Of The Leland Stanford Junior University |
Adenoviral vector and methods for making and using the same
|
US6929946B1
(en)
|
1998-11-20 |
2005-08-16 |
Crucell Holland B.V. |
Gene delivery vectors provided with a tissue tropism for smooth muscle cells, and/or endothelial cells
|
US6380364B1
(en)
*
|
1998-11-23 |
2002-04-30 |
Loyola University Of Chicago |
Chimeric biotin-binding papillomavirus protein
|
JP2000279178A
(ja)
*
|
1999-02-24 |
2000-10-10 |
Japan Found Cancer Res |
ウイルスベクター
|
US20040009936A1
(en)
*
|
1999-05-03 |
2004-01-15 |
Tang De-Chu C. |
Vaccine and drug delivery by topical application of vectors and vector extracts
|
US6492169B1
(en)
|
1999-05-18 |
2002-12-10 |
Crucell Holland, B.V. |
Complementing cell lines
|
US6913922B1
(en)
|
1999-05-18 |
2005-07-05 |
Crucell Holland B.V. |
Serotype of adenovirus and uses thereof
|
US20040014033A1
(en)
*
|
1999-06-30 |
2004-01-22 |
Evotec Biosystems Ag, A Corporation Of Germany |
Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics
|
US7476517B2
(en)
|
1999-06-30 |
2009-01-13 |
Evotec Ag |
Virus like particles, their preparation and their use preferably in pharmaceutical screening and functional genomics
|
DE60034947T2
(de)
*
|
1999-06-30 |
2008-01-24 |
Evotec Ag |
Virusähnliche partikel, vorbereitung und verwendung in screening und funktionelle genomanwendung
|
US6461869B1
(en)
*
|
1999-07-20 |
2002-10-08 |
Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College |
Purging leukemia cells from hematopoietic stem cells
|
EP1220914A1
(en)
*
|
1999-09-16 |
2002-07-10 |
Solvay Pharmaceuticals B.V. |
Human g-protein coupled receptor
|
DE1221490T1
(de)
*
|
1999-09-17 |
2003-05-28 |
Tgt Lab S A De C V |
Rekombinante, adenovirale vektoren und ihre verwendung zur behandlung von unterschiedlichen typen der leber-, nieren- und lungenfibrose und hypertrophischen narben
|
EP1223947A4
(en)
*
|
1999-10-15 |
2004-12-08 |
Canji Inc |
TARGETED VECTORS
|
GB0008966D0
(en)
|
2000-04-13 |
2000-05-31 |
Imp College Innovations Ltd |
Vectors for gene therapy
|
CA2341356C
(en)
*
|
2000-04-14 |
2011-10-11 |
Transgene S.A. |
Poxvirus with targeted infection specificity
|
US7348014B2
(en)
|
2000-04-14 |
2008-03-25 |
Transgene, S.A. |
Poxvirus with targeted infection specificity
|
EP1276888A2
(en)
*
|
2000-04-26 |
2003-01-22 |
Crucell Holland B.V. |
Adenovirus vectors with knobless fibers, and their uses
|
US6680172B1
(en)
|
2000-05-16 |
2004-01-20 |
Regents Of The University Of Michigan |
Treatments and markers for cancers of the central nervous system
|
WO2001092549A2
(en)
*
|
2000-05-31 |
2001-12-06 |
Genvec, Inc. |
Method and composition for targeting an adenoviral vector
|
US6762031B2
(en)
|
2000-06-16 |
2004-07-13 |
University Of Medicine And Dentistry Of New Jersey |
Targeting viral vectors to specific cells
|
GB0017720D0
(en)
*
|
2000-07-19 |
2000-09-06 |
Got A Gene Ab |
Modified virus
|
US20080194022A1
(en)
*
|
2000-08-03 |
2008-08-14 |
Clarke Michael F |
Isolation and use of solid tumor stem cells
|
US8044259B2
(en)
|
2000-08-03 |
2011-10-25 |
The Regents Of The University Of Michigan |
Determining the capability of a test compound to affect solid tumor stem cells
|
US6984522B2
(en)
|
2000-08-03 |
2006-01-10 |
Regents Of The University Of Michigan |
Isolation and use of solid tumor stem cells
|
GB0019302D0
(en)
*
|
2000-08-08 |
2000-09-27 |
Univ Nottingham Trent |
Biological materials and the use thereof for the treatment of disease
|
US7235233B2
(en)
|
2000-09-26 |
2007-06-26 |
Crucell Holland B.V. |
Serotype 5 adenoviral vectors with chimeric fibers for gene delivery in skeletal muscle cells or myoblasts
|
JP4802401B2
(ja)
*
|
2000-11-07 |
2011-10-26 |
トランスジェン・ソシエテ・アノニム |
標的化感染特異性を有するポックスウイルス
|
MXPA00011713A
(es)
*
|
2000-11-28 |
2002-05-31 |
Tgt Lab S A De C V |
Vectores recombinantes virales y no virales conteniendo el gen humano del activador de plasminogeno derivado de urocinasa y su utilidad en el tratamiento de diversos tipos de fibrosis hepatica, renal, pulmonar, pancreatica, cardiaca y cicatrices hipe
|
CA2432542A1
(en)
|
2000-12-22 |
2002-07-04 |
Synovis Limited |
Methods of modulating toll-related receptor (trr) signaling
|
US20040126774A1
(en)
*
|
2001-01-08 |
2004-07-01 |
Mitchell Lioyd G. |
Correction of factor VIII genetic defects using spliceosome mediated RNA trans splicing
|
ATE527375T1
(de)
|
2001-04-12 |
2011-10-15 |
Imp Innovations Ltd |
Diagnose und behandlung von brustkrebs mit scn5a
|
GB0111324D0
(en)
|
2001-05-09 |
2001-07-04 |
Unilever Plc |
Ambient stable beverage
|
WO2002094318A1
(en)
*
|
2001-05-18 |
2002-11-28 |
University Of Southern California |
Vector for targeted delivery to cells
|
US7449562B2
(en)
*
|
2001-06-29 |
2008-11-11 |
Novartis Ag |
PERV screening method and use thereof
|
US7229774B2
(en)
|
2001-08-02 |
2007-06-12 |
Regents Of The University Of Michigan |
Expression profile of prostate cancer
|
GB0119852D0
(en)
*
|
2001-08-15 |
2001-10-10 |
Univ York |
Baculovirus
|
EP1427816A4
(en)
|
2001-09-18 |
2004-12-01 |
Clontech Lab Inc |
METHOD FOR PRODUCING ADENOVIRAL VECTORS BASED ON A SITE SPECIFIC RECOMBINASE
|
WO2003057916A2
(en)
|
2002-01-09 |
2003-07-17 |
Riken |
Cancer profiles
|
US7399753B2
(en)
*
|
2002-02-25 |
2008-07-15 |
Virxsys Corporation |
Trans-splicing mediated photodynamic therapy
|
DK1497438T3
(da)
|
2002-04-25 |
2010-01-04 |
Crucell Holland Bv |
Midler og fremgangsmåder til fremstilling af adenovirusvektorer
|
CA2485341A1
(en)
*
|
2002-05-08 |
2004-06-17 |
Intronn, Inc. |
Use of spliceosome mediated rna trans-splicing to confer cell selective replication to adenoviruses
|
EP1579004B1
(en)
*
|
2002-10-23 |
2010-06-16 |
VIRxSYS Corporation |
Screening methods for identification of efficient pre-trans-splicing molecules
|
US20040166091A1
(en)
|
2003-02-24 |
2004-08-26 |
Genvec, Inc. |
Materials and methods for treating disorders of the ear
|
WO2004101799A2
(en)
|
2003-05-14 |
2004-11-25 |
Istituto Di Ricerche Di Biologia Molecolare P Angeletti Spa |
Broadening adenovirus tropism
|
US20060019256A1
(en)
*
|
2003-06-09 |
2006-01-26 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
DE602004031681D1
(de)
|
2003-07-21 |
2011-04-14 |
Transgene Sa |
Multifunktionelle Cytokine
|
ES2391975T3
(es)
*
|
2003-07-25 |
2012-12-03 |
Genvec, Inc. |
Vacunas a base de vector adenovírico
|
CA2542674A1
(en)
*
|
2003-10-15 |
2005-04-28 |
Board Of Regents, The University Of Texas System |
Multifunctional biomaterials as scaffolds for electronic, optical, magnetic, semiconducting, and biotechnological applications
|
JP2007513261A
(ja)
*
|
2003-10-15 |
2007-05-24 |
ボード・オブ・リージエンツ,ザ・ユニバーシテイ・オブ・テキサス・システム |
ウイルスファイバー
|
JP2007511507A
(ja)
*
|
2003-11-14 |
2007-05-10 |
ジェンベク、インコーポレイティッド |
癌を処置するための治療レジメン
|
US7923109B2
(en)
|
2004-01-05 |
2011-04-12 |
Board Of Regents, The University Of Texas System |
Inorganic nanowires
|
WO2005075506A1
(en)
*
|
2004-01-09 |
2005-08-18 |
The Scripps Research Institute |
Identification of endogenous trimerization domains in the adenovirus fiber protein that allow detargeting and retargeting of viral vectors
|
JP2007518423A
(ja)
*
|
2004-01-23 |
2007-07-12 |
イントロン、インコーポレイテッド |
スプライセオソーム仲介型rnaトランススプライシングを使用するアポa−1及びその変異体の発現
|
WO2005070948A1
(en)
*
|
2004-01-23 |
2005-08-04 |
Intronn, Inc. |
Correction of alpha-1-antitrypsin genetic defects using spliceosome mediated rna trans splicing
|
US7968334B2
(en)
*
|
2004-01-23 |
2011-06-28 |
Virxsys Corporation |
Expression of apoAI and variants thereof using spliceosome mediated RNA trans-splicing
|
US20050232927A1
(en)
*
|
2004-02-03 |
2005-10-20 |
The Regents Of The University Of Michigan |
Compositions and methods for characterizing, regulating, diagnosing, and treating cancer
|
EP2567967A3
(en)
|
2004-04-12 |
2013-08-21 |
GOVERNMENT OF THE UNITED STATES OF AMERICA, as represented by THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES |
Method of using adenoviral vectors to induce an immune response
|
JP2008505853A
(ja)
*
|
2004-04-13 |
2008-02-28 |
クインテセンス バイオサイエンシーズ インコーポレーティッド |
細胞傷害性薬剤としての非天然のリボヌクレアーゼ複合体
|
CA2567156A1
(en)
*
|
2004-05-17 |
2006-07-20 |
Cambrios Technology Corp. |
Biofabrication of transistors including field effect transistors
|
US7858323B2
(en)
|
2004-06-09 |
2010-12-28 |
The Regents Of The University Of Michigan |
Phage microarray profiling of the humoral response to disease
|
US20060094110A1
(en)
*
|
2004-07-30 |
2006-05-04 |
Mcgarrity Gerard J |
Use of spliceosome mediated RNA trans-splicing for immunotherapy
|
US20060134658A1
(en)
*
|
2004-08-09 |
2006-06-22 |
Garcia-Blanco Mariano A |
Use of RNA trans-splicing for generation of interfering RNA molecules
|
CA2589602A1
(en)
*
|
2004-09-01 |
2006-04-13 |
Genvec, Inc. |
Adenoviral vectors able to transduce apcs, potential use in immune response generation
|
DE102004047492B4
(de)
*
|
2004-09-23 |
2006-07-20 |
Jost-Werke Gmbh & Co. Kg |
Verfahren zum Übertragen von elektrischer, pneumatischer oder hydraulischer Energie sowie ein Energieübertragungssystem
|
EP1799243B1
(en)
|
2004-10-06 |
2015-07-15 |
University Of Rochester |
Treatment of pulmonary hypertension using an agent that inhibits a tissue factor pathway
|
US7879321B2
(en)
*
|
2004-10-08 |
2011-02-01 |
Virxsys Corporation |
Use of RNA trans-splicing for antibody gene transfer and antibody polypeptide production
|
US7871795B2
(en)
|
2004-10-08 |
2011-01-18 |
Virxsys Corporation |
Targeted trans-splicing of highly abundant transcripts for in vivo production of recombinant proteins
|
WO2006067402A2
(en)
|
2004-12-22 |
2006-06-29 |
Lipopeptide Ab |
Agents inibiting the cathelin-like protein cap18/ll-37
|
WO2006078853A2
(en)
|
2005-01-20 |
2006-07-27 |
University Of Rochester |
Thioredoxin interacting protein (txnip) as regulator of vascular function
|
CA2598806A1
(en)
*
|
2005-02-23 |
2006-08-31 |
Uab Research Foundation |
Alkyl-glycoside enhanced vaccination
|
WO2006138275A2
(en)
*
|
2005-06-13 |
2006-12-28 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
WO2006135886A2
(en)
*
|
2005-06-13 |
2006-12-21 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
WO2007027860A2
(en)
*
|
2005-08-31 |
2007-03-08 |
Genvec, Inc. |
Adenoviral vector-based malaria vaccines
|
CA2814598A1
(en)
|
2005-09-12 |
2007-03-22 |
The Regents Of The University Of Michigan |
Recurrent gene fusions in prostate cancer
|
US8652467B2
(en)
*
|
2005-10-14 |
2014-02-18 |
The Regents Of The University Of Michigan |
Dek protein compositions and methods of using the same
|
US7794951B2
(en)
*
|
2005-10-18 |
2010-09-14 |
University Of Massachusetts Medical School |
SREBP2gc transcription factors and uses thereof
|
CA2628255C
(en)
|
2005-10-31 |
2016-04-19 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing cancer
|
HUE025908T2
(en)
|
2005-10-31 |
2016-04-28 |
Oncomed Pharm Inc |
Preparations and procedures for the diagnosis and treatment of cancer
|
US7723477B2
(en)
|
2005-10-31 |
2010-05-25 |
Oncomed Pharmaceuticals, Inc. |
Compositions and methods for inhibiting Wnt-dependent solid tumor cell growth
|
BRPI0618441B8
(pt)
*
|
2005-11-10 |
2021-07-27 |
Genvec Inc |
vetor adenoviral
|
WO2008057127A2
(en)
*
|
2006-02-06 |
2008-05-15 |
Massachusetts Institute Of Technology |
Self-assembly of macromolecules on multilayered polymer surfaces
|
GB0607354D0
(en)
|
2006-04-12 |
2006-05-24 |
Bioinvent Int Ab |
Agent, Composition And Method
|
US7393699B2
(en)
|
2006-06-12 |
2008-07-01 |
Tran Bao Q |
NANO-electronics
|
JP2009541333A
(ja)
*
|
2006-06-23 |
2009-11-26 |
クインテセンス バイオサイエンシーズ インコーポレーティッド |
修飾リボヌクレアーゼ
|
US8298801B2
(en)
|
2006-07-17 |
2012-10-30 |
Quintessence Biosciences, Inc. |
Methods and compositions for the treatment of cancer
|
US20080261216A1
(en)
*
|
2006-09-08 |
2008-10-23 |
The Regents Of The University Of Michigan |
HERV Group II Viruses In Lymphoma And Cancer
|
US20100278870A1
(en)
*
|
2007-01-09 |
2010-11-04 |
The Henry M. Jackson Foundation For The Advancement Of Military Medicine, Inc. |
Adenoviral vector-based malaria vaccines
|
WO2008092002A2
(en)
*
|
2007-01-24 |
2008-07-31 |
The Regents Of The University Of Michigan |
Compositions and methods for treating and diagnosing pancreatic cancer
|
CN101617052A
(zh)
|
2007-01-30 |
2009-12-30 |
特兰斯吉恩股份有限公司 |
用于免疫的乳头瘤病毒e2多肽
|
US20090324596A1
(en)
|
2008-06-30 |
2009-12-31 |
The Trustees Of Princeton University |
Methods of identifying and treating poor-prognosis cancers
|
US10745701B2
(en)
|
2007-06-28 |
2020-08-18 |
The Trustees Of Princeton University |
Methods of identifying and treating poor-prognosis cancers
|
CA2814246A1
(en)
|
2007-07-06 |
2009-01-15 |
The Regents Of The University Of Michigan |
Solute carrier family 45 member 3 (slc45a3) and erg family gene fusions in prostate cancer
|
US20090047269A1
(en)
|
2007-08-16 |
2009-02-19 |
The Regents Of The University Of Michigan |
Metabolomic cancer targets
|
US8697062B2
(en)
*
|
2007-10-08 |
2014-04-15 |
Quintessence Biosciences, Inc. |
Compositions and methods for ribonuclease-based therapeutics
|
US8518884B2
(en)
|
2008-04-25 |
2013-08-27 |
Northwestern University |
Methods for treating atrial or ventricular arrhythmias by administering a G-protein alpha inhibitor
|
US8193151B2
(en)
*
|
2008-04-25 |
2012-06-05 |
Northwestern University |
Methods for treating atrial or ventricular arrhythmias
|
CA2724231A1
(en)
*
|
2008-05-15 |
2009-11-19 |
The University Of North Carolina At Chapel Hill |
Novel targets for regulation of angiogenesis
|
AU2009256202B2
(en)
|
2008-06-04 |
2014-07-03 |
FUJIFILM Cellular Dynamics, Inc. |
Methods for the production of IPS cells using non-viral approach
|
MX2011003183A
(es)
|
2008-09-26 |
2011-04-21 |
Oncomed Pharm Inc |
Agentes que se unen a receptor encrespado y usos de los mismos.
|
EP2334695B1
(en)
|
2008-10-01 |
2015-12-23 |
Quintessence Biosciences, Inc. |
Therapeutic ribonucleases
|
DK2356221T3
(en)
|
2008-10-24 |
2019-02-18 |
Wisconsin Alumni Res Found |
Pluripotent stem cells obtained by non-viral reprogramming
|
EP2382328A2
(en)
|
2009-01-09 |
2011-11-02 |
The Regents of the University of Michigan |
Recurrent gene fusions in cancer
|
WO2010085665A2
(en)
|
2009-01-23 |
2010-07-29 |
Cedars-Sinai Medical Center |
Targeted delivery system
|
WO2010107991A2
(en)
|
2009-03-18 |
2010-09-23 |
Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Use of ixolaris, a tissue factor inhibitor, for the treatment and prevention of cancer
|
ES2385251B1
(es)
|
2009-05-06 |
2013-05-06 |
Fundació Privada Institut D'investigació Biomèdica De Bellvitge |
Adenovirus oncolíticos para el tratamiento del cáncer.
|
DK2548950T3
(en)
|
2009-06-05 |
2017-12-11 |
Cellular Dynamics Int Inc |
Reprogramming of T cells and hematopoietic cells
|
WO2010144711A2
(en)
|
2009-06-10 |
2010-12-16 |
New York University |
Immunological targeting of pathological tau proteins
|
GB0910620D0
(en)
|
2009-06-19 |
2009-08-05 |
Immunovia Ab |
Agents and uses thereof
|
EP2451837B1
(en)
|
2009-07-08 |
2015-03-25 |
Cellular Dynamics International, Inc. |
Modified ips cells having a mutant form of human immunodeficiency virus (hiv) cellular entry gene
|
GB0912624D0
(en)
|
2009-07-21 |
2009-08-26 |
Imp Innovations Ltd |
Methods
|
JP5897464B2
(ja)
|
2009-08-07 |
2016-03-30 |
トランジェーヌ、ソシエテ、アノニムTransgene S.A. |
Hbv感染を治療するための組成物
|
ES2509567T3
(es)
|
2009-08-28 |
2014-10-17 |
Cellular Dynamics International, Inc. |
Identificación de variación genética en tejidos afectados
|
US9605844B2
(en)
*
|
2009-09-01 |
2017-03-28 |
Cree, Inc. |
Lighting device with heat dissipation elements
|
EP2473529B1
(en)
|
2009-09-03 |
2016-02-10 |
Cancer Research Technology Limited |
Clec14a inhibitors
|
US20120219583A1
(en)
|
2009-10-16 |
2012-08-30 |
Los Alamos National Security, Llc |
Nucleic acid sequences encoding expandable hiv mosaic proteins
|
US8415155B2
(en)
|
2009-10-19 |
2013-04-09 |
Cellular Dynamics International, Inc. |
Cardiomyocyte production
|
AU2010314842A1
(en)
|
2009-11-09 |
2012-05-31 |
Genvec, Inc. |
Methods of propagating monkey adenoviral vectors
|
WO2011057254A2
(en)
|
2009-11-09 |
2011-05-12 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Simian adenoviral vector-based vaccines
|
TWI535445B
(zh)
|
2010-01-12 |
2016-06-01 |
安可美德藥物股份有限公司 |
Wnt拮抗劑及治療和篩選方法
|
US8592364B2
(en)
*
|
2010-02-11 |
2013-11-26 |
Ecole Polytechnique Federale de Lausanne (“EPFL”) |
CCR7 ligand delivery and co-delivery in immunotherapy
|
US20110237461A1
(en)
*
|
2010-03-17 |
2011-09-29 |
The Regents Of The University Of Michigan |
Using phage epitopes to profile the immune response
|
WO2011119524A1
(en)
*
|
2010-03-22 |
2011-09-29 |
The University Of North Carolina At Chapel Hill |
Novel targets for regulation of angiogenesis
|
CN102971337B
(zh)
|
2010-04-01 |
2016-09-21 |
昂考梅德药品有限公司 |
卷曲蛋白结合药剂及其应用
|
GB201105584D0
(en)
|
2011-04-01 |
2011-05-18 |
Imp Innovations Ltd |
Cancer methods
|
EP3382008A1
(en)
|
2010-06-15 |
2018-10-03 |
FUJIFILM Cellular Dynamics, Inc. |
Generation of induced pluripotent stem cells from small volumes of peripheral blood
|
KR101861171B1
(ko)
|
2010-06-18 |
2018-05-31 |
후지필름 셀룰러 다이내믹스, 인코포레이티드 |
투석된 혈청이 있는 심근세포 배지
|
RU2011136591A
(ru)
*
|
2010-06-23 |
2014-07-27 |
Олег Федорович Михейцев |
Антибактериальный и/или противогрибковый компонент, обладающий свойством специфически связываться с бактериями и/или грибами
|
WO2012006440A2
(en)
|
2010-07-07 |
2012-01-12 |
Cellular Dynamics International, Inc. |
Endothelial cell production by programming
|
JP6017422B2
(ja)
|
2010-08-10 |
2016-11-02 |
エコール・ポリテクニーク・フェデラル・ドゥ・ローザンヌ(ウペエフエル)Ecole Polytechnique Federale de Lausanne (EPFL) |
赤血球結合療法
|
US9850296B2
(en)
|
2010-08-10 |
2017-12-26 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Erythrocyte-binding therapeutics
|
US9517257B2
(en)
|
2010-08-10 |
2016-12-13 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Erythrocyte-binding therapeutics
|
WO2012021730A2
(en)
|
2010-08-11 |
2012-02-16 |
Genvec, Inc. |
Respiratory syncytial virus (rsv) vaccine
|
WO2012083297A2
(en)
|
2010-12-17 |
2012-06-21 |
Genvec, Inc. |
Adenoviral vectors with modified hexon regions
|
WO2012088041A1
(en)
|
2010-12-20 |
2012-06-28 |
Genvec, Inc. |
Adenoviral vector-based dengue fever vaccine
|
WO2012092341A1
(en)
|
2010-12-28 |
2012-07-05 |
University Of Rochester |
Methods of modifying insulin signaling using biliverdin reductase (bvr) and bvr derived peptides
|
JP6185907B2
(ja)
|
2011-03-30 |
2017-08-23 |
セルラー ダイナミクス インターナショナル, インコーポレイテッド |
神経分化のための多能性幹細胞の予備刺激
|
WO2013001372A2
(en)
|
2011-06-30 |
2013-01-03 |
University Of Oslo |
Methods and compositions for inhibition of activation of regulatory t cells
|
CN103813805B
(zh)
|
2011-07-06 |
2017-02-22 |
索兰徳特医院 |
Egfr靶向疗法
|
GB201115280D0
(en)
|
2011-09-05 |
2011-10-19 |
Alligator Bioscience Ab |
Antibodies, uses and methods
|
WO2013036875A1
(en)
|
2011-09-07 |
2013-03-14 |
Mount Sinai School Of Medicine |
Ceramidase and cell differentiation
|
DK2797613T3
(da)
|
2011-10-27 |
2020-03-02 |
Wellstat Ophthalmics Corp |
Vektorer, der koder for rod-derived cone viability-faktor
|
US20150147274A1
(en)
|
2011-12-02 |
2015-05-28 |
Cancer Research Technology Limited |
Antibodies against hgf - receptor and uses
|
CN110075284A
(zh)
|
2012-02-15 |
2019-08-02 |
洛桑聚合联合学院 |
红细胞结合性治疗剂
|
EP2830499B8
(en)
|
2012-03-30 |
2019-04-03 |
Insulet Corporation |
Fluid delivery device with transcutaneous access tool, insertion mechansim and blood glucose monitoring for use therewith
|
EP2855669B1
(en)
|
2012-05-29 |
2018-10-10 |
GenVec, Inc. |
Modified serotype 28 adenoviral vectors
|
CA2881582A1
(en)
|
2012-08-03 |
2014-02-06 |
Cedars-Sinai Medical Center |
Isolating traffic-enhancing mutants of drug delivery protein
|
WO2014063155A1
(en)
|
2012-10-21 |
2014-04-24 |
University Of Rochester |
Thy1 (cd90) as a novel therapy to control adipose tissue accumulation
|
WO2014066328A1
(en)
|
2012-10-23 |
2014-05-01 |
Oncomed Pharmaceuticals, Inc. |
Methods of treating neuroendocrine tumors using wnt pathway-binding agents
|
CN104870477B
(zh)
|
2012-10-23 |
2018-10-09 |
爱默蕾大学 |
Gm-csf和il-4轭合物、组合物以及与其相关的方法
|
BR112015013849A2
(pt)
|
2012-12-21 |
2017-07-11 |
Sykehuset Soerlandet Hf |
terapia direcionada a egfr de distúrbios neurológicos e dor
|
EP2950885B1
(en)
|
2013-02-04 |
2018-11-21 |
Oncomed Pharmaceuticals, Inc. |
Methods and monitoring of treatment with a wnt pathway inhibitor
|
US20140242595A1
(en)
|
2013-02-22 |
2014-08-28 |
Cellular Dynamics International, Inc. |
Hepatocyte production via forward programming by combined genetic and chemical engineering
|
US9168300B2
(en)
|
2013-03-14 |
2015-10-27 |
Oncomed Pharmaceuticals, Inc. |
MET-binding agents and uses thereof
|
EP2981605B1
(en)
|
2013-04-03 |
2019-06-19 |
FUJIFILM Cellular Dynamics, Inc. |
Methods and compositions for culturing endoderm progenitor cells in suspension
|
WO2014176259A1
(en)
|
2013-04-22 |
2014-10-30 |
Icahn School Of Medicine At Mount Sinai |
Mutations in pdgfrb and notch3 as causes of autosomal dominant infantile myofibromatosis
|
WO2015095882A1
(en)
|
2013-12-20 |
2015-06-25 |
The Regents Of The University Of California |
Biomimetic virus-based colorimetric sensors
|
US10946079B2
(en)
|
2014-02-21 |
2021-03-16 |
Ecole Polytechnique Federale De Lausanne |
Glycotargeting therapeutics
|
NZ723879A
(en)
|
2014-02-21 |
2018-03-23 |
Ecole Polytechnique Fed Lausanne Epfl |
Glycotargeting therapeutics
|
US10953101B2
(en)
|
2014-02-21 |
2021-03-23 |
École Polytechnique Fédérale De Lausanne (Epfl) |
Glycotargeting therapeutics
|
US10046056B2
(en)
|
2014-02-21 |
2018-08-14 |
École Polytechnique Fédérale De Lausanne (Epfl) |
Glycotargeting therapeutics
|
US9694036B2
(en)
|
2014-03-21 |
2017-07-04 |
Cellular Dynamics International, Inc. |
Production of midbrain dopaminergic neurons and methods for the use thereof
|
WO2015164228A1
(en)
|
2014-04-21 |
2015-10-29 |
Cellular Dynamics International, Inc. |
Hepatocyte production via forward programming by combined genetic and chemical engineering
|
TWI710635B
(zh)
|
2014-10-09 |
2020-11-21 |
美商珍維克公司 |
編碼人類無調同源物-1(hath1)之腺病毒載體
|
US11273151B2
(en)
|
2015-11-04 |
2022-03-15 |
Icahn School Of Medicine At Mount Sinai |
Methods of treating tumors and cancer, and identifying candidate subjects for such treatment
|
US10377801B2
(en)
|
2015-11-04 |
2019-08-13 |
Northwestern University |
Amelioration of chronic kidney disease
|
WO2017091584A1
(en)
|
2015-11-25 |
2017-06-01 |
Insulet Corporation |
Wearable medication delivery device
|
EP3448881B1
(en)
|
2016-04-26 |
2023-06-07 |
Icahn School of Medicine at Mount Sinai |
Treatment of hippo pathway mutant tumors and methods of identifying subjects as candidates for treatment
|
WO2018013509A1
(en)
|
2016-07-11 |
2018-01-18 |
Arizona Board Of Regents On Behalf Of The University Of Arizona |
Compositions and methods for diagnosing and treating arrhythmias
|
WO2018064523A1
(en)
|
2016-09-30 |
2018-04-05 |
Genvec, Inc. |
Adenovectors for delivery of therapeutic genetic material into t cells
|
US11241436B2
(en)
|
2017-01-25 |
2022-02-08 |
Northwestern University |
Autophagy inducers for treatment of CNS conditions
|
US11045603B2
(en)
|
2017-02-22 |
2021-06-29 |
Insulet Corporation |
Needle insertion mechanisms for drug containers
|
WO2018232176A1
(en)
|
2017-06-16 |
2018-12-20 |
The University Of Chicago |
Compositions and methods for inducing immune tolerance
|
EP3687600B1
(en)
|
2017-09-26 |
2022-04-27 |
Insulet Corporation |
Needle mechanism module for drug delivery device
|
US11147931B2
(en)
|
2017-11-17 |
2021-10-19 |
Insulet Corporation |
Drug delivery device with air and backflow elimination
|
CA3083183A1
(en)
|
2017-11-22 |
2019-05-31 |
The Regents Of The University Of Michigan |
Compositions and methods for treating cancer
|
EP3927833A4
(en)
|
2019-02-21 |
2022-11-30 |
Unleash Immuno Oncolytics, Inc. |
ONCOLYTIC ADENOVIRAL VECTOR AND METHODS OF USE
|
WO2022035863A1
(en)
|
2020-08-11 |
2022-02-17 |
Musculoskeletal Transplant Foundation |
Method for treating cardiac conditions with placenta-derived compositions
|